Finance

Lists
CLYYF:OTCMKTS
Celyad Oncology SA
$0.28
0.00%
(0.00) 1D
Aug 7, 1:29:32 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLYYF...
Mkt. cap
9.90M
Volume
0.00
52-wk high
$0.35
52-wk low
$0.15
Shares outstanding
47.26M
No. of employees
5
Mkt. cap
9.90M
Volume
0.00
52-wk high
$0.35
52-wk low
$0.15
Shares outstanding
47.26M
No. of employees
5
News stories
From web sources and news partners
About Celyad Oncology SA
CEOFilippo Petti
Employees5
Founded2004
HeadquartersMont-Saint-Guibert, Walloon Brabant, Belgium
SectorBiotechnology
Websitecelyad.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.50K
3.50K
-
-
Cost of goods sold
-
-
2.00K
2.00K
Cost of revenue
-
-
2.00K
2.00K
Research and development expenses
669.00K
669.00K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.05M
1.05M
190.00K
190.00K
Operating expense
-1.06M
-1.06M
597.00K
597.00K
Total operating expenses
-1.06M
-1.06M
599.00K
599.00K
Operating income
1.06M
1.06M
-599.00K
-599.00K
Other non operating income
1.00K
1.00K
500.00
500.00
EBT including unusual items
2.25M
2.25M
-605.00K
-605.00K
EBT excluding unusual items
1.05M
1.05M
-605.00K
-605.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-2.78M
-2.78M
385.50K
385.50K
Net income
2.25M
2.25M
-605.00K
-605.00K
Net profit margin
64,357.14%
64,357.14%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.00K
1.00K
Interest expense
-16.00K
-16.00K
-7.50K
-7.50K
Net interest expenses
-16.00K
-16.00K
-6.50K
-6.50K
Depreciation and amortization charges
-
-
21.50K
21.50K
EBITDA
1.10M
1.07M
-577.50K
-577.50K
Gain or loss from assets sale
-1.15M
-1.15M
-115.50K
-115.50K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps